Advanced search
Start date
Betweenand


Dynamics of the personalities of PCSK9 on missense variants (rs505151 and rs562556) from elderly cohort studies in Brazil

Full text
Author(s):
Lopes, Vitor Galvao ; de Oliveira, Victor Fernandes ; Dati, Livia Mendonca Munhoz ; Naslavsky, Michel Satya ; Ferreira, Glaucio Monteiro ; Hirata, Mario Hiroyuki
Total Authors: 6
Document type: Journal article
Source: JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS; v. N/A, p. 9-pg., 2023-03-25.
Abstract

The Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) promotes the degradation of the low-density lipoprotein receptors (LDLR). Gain-of-function (GOF) variants of PCSK9 significantly affects lipid metabolism leading to coronary artery disease (CAD), owing to the raising the plasma low-density lipoprotein (LDL). Considering the public health matter, large-scale genomic studies have been conducted worldwide to provide the genetic architecture of populations for the implementation of precision medicine actions. Nevertheless, despite the advances in genomic studies, non-European populations are still underrepresented in public genomic data banks. Despite this, we found two high-frequency variants (rs505151 and rs562556) in the ABraOM databank (Brazilian genomic variants) from a cohort SABE study conducted in the largest city of Brazil, Sao Paulo. Here, we assessed the structural and dynamical features of these variants against WT through a molecular dynamics study. We sought fundamental dynamical interdomain relations through Perturb Response Scanning (PRS) and we found an interesting change of dynamical relation between prodomain and Cysteine-Histidine-Rich-Domain (CHRD) in the variants. The results highlight the pivotal role of prodomain in the PCSK9 dynamic and the implications for the development of new drugs depending on patient group genotype. (AU)

FAPESP's process: 21/11205-9 - Development of new drugs based on the structure of essential proteins for cholesterol synthesis and metabolism, integrating genetic studies and molecular modeling of dyslipidemic patients
Grantee:Glaucio Monteiro Ferreira
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 16/12899-6 - Genomics, epigenomics and pharmacogenomics characterization of familial hypercholesterolemia in the Brazilian population
Grantee:Mario Hiroyuki Hirata
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 18/11917-6 - Development of a specific pipeline of bioinformatics
Grantee:Victor Fernandes de Oliveira
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 20/06490-3 - Search a new PCSK9 inhibitor using techniques of drug planning based on a target structure
Grantee:Vitor Galvão Lopes
Support Opportunities: Scholarships in Brazil - Scientific Initiation